7th NCCN Annual Congress: Hematologic Malignancies™

Myelodysplastic Syndromes:

• Current Developments in the Management of Myelodysplastic Syndromes

Chronic Myelogenous Leukemia:

• Managing Suboptimal Response to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia
• Overcoming Resistance to Tyrosine Kinase Inhibitors in Ph-positive Leukemias
• Management of Relapsed/Refractory Acute Lymphoblastic Leukemia
• Supportive Care Issues in Patients with Acute Lymphoblastic Leukemia

Lymphomas:

• Management of Chronic Lymphocytic Leukemia in the Elderly Population
• Post-Remission Strategies in Aggressive Lymphomas
• Role of Interim and Surveillance Imaging in Lymphomas
• New Treatment Options in the Management of Relapsed/Refractory Hodgkin Lymphoma

Multiple Myeloma:

• Expert Recommendations in Treatment of Newly Diagnosed Multiple Myeloma
• Maintenance Therapy in Multiple Myeloma

Transplant:

• Strategies for Stem Cell Mobilization

Supportive Care:

• Management of Anemia
• New and Emerging Agents in the Prevention and Treatment of Venous Thromboembolic Disease
• Managing Idiopathic Thrombocytopenic Purpura